Book Review: Beyond Normal: How the New Science of Enhanced Medicine Elevates Peak Performance and Repairs Brain Injuries (2024) | Amplify Publishing | Available on Amazon and Barnes & Noble
Here is a thought experiment. Imagine your doctor visits you after a routine checkup and, instead of saying “everything looks normal for your age,” she says: “You’re functioning at about 60% of your biological potential. Want to do something about that?”
That reframe — from normal to optimal — is the engine of Dr. Shai Efrati’s compelling, occasionally breathless, and genuinely important book. Beyond Normal is not primarily a book about being sick. It is about the astonishing possibility that modern medicine has been setting its ambitions far too low.
Who Is Dr. Shai Efrati?
Dr. Shai Efrati is a physician specializing in internal medicine, nephrology (kidney medicine), and hyperbaric medicine. He is the director of the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center in Israel — the largest hyperbaric medicine center in the world, treating more than 350 patients per day. He also serves as a professor at Tel Aviv University’s medical school and the Sagol School of Neuroscience, and is co-founder of Aviv Clinics, which brings his hyperbaric oxygen therapy (HBOT) protocols to a clinical setting.
With over 170 peer-reviewed scientific publications, Efrati is not a wellness influencer moonlighting as a doctor. He is a serious clinical researcher whose work sits at the intersection of hyperbaric medicine, neuroplasticity, and aging science. That credibility matters when evaluating what he claims.
The Central Idea: Enhanced Medicine
For decades, medicine has aimed at restoration — getting a sick person back to “normal.” HBOT, short for hyperbaric oxygen therapy, has long been used in that role: treating decompression sickness in divers, healing stubborn diabetic wounds, clearing carbon monoxide poisoning.
Efrati’s argument is that this is thinking much too small.
His “enhanced medicine” framework asks a different question: not “can we restore you to baseline?” but “can we push your physiology beyond where it started?” He argues that recent advances in molecular biology have revealed mechanisms by which the body can regenerate, repair, and genuinely enhance function — at any age — if given the right stimuli.
The cornerstone of this approach is a specific, precisely calibrated HBOT protocol that Efrati’s team spent nearly two decades developing at the Sagol Center.
The Science: The Hyperoxic-Hypoxic Paradox
The most conceptually fascinating part of the book is Efrati’s explanation of what he calls the hyperoxic-hypoxic paradox — the mechanism he believes drives much of HBOT’s regenerative power.
Here is how it works. The most powerful biological trigger for regeneration in the human body is hypoxia — a lack of sufficient oxygen. When tissues are starved of oxygen, the body kicks into repair mode: stem cells proliferate, new blood vessels grow (angiogenesis), mitochondria multiply. The problem with actually inducing hypoxia as therapy is obvious — low oxygen is dangerous.
Efrati’s protocol exploits a loophole. By placing patients in a hyperbaric chamber breathing pure oxygen at elevated pressure, and then periodically cycling that oxygen on and off in precise intervals, the body perceives a relative drop in oxygen even while it is technically swimming in the stuff. The tissues register a hypoxic signal. The regenerative cascade fires. But the patient remains safe and well-oxygenated throughout.
The result, Efrati’s team found across multiple randomized controlled clinical trials: measurable increases in stem cell circulation, new blood vessel formation, mitochondrial proliferation, and — critically — neuroplasticity. The brain, long assumed to be largely fixed after injury or age, begins to remodel itself.
The Evidence: What the Research Shows
This is where the book earns its keep, and where skeptical readers should pay closest attention.
Efrati is not making claims without backing. His group has published peer-reviewed trials demonstrating HBOT’s effects across a striking range of conditions:
Post-stroke recovery. A randomized controlled trial published in PLOS ONE showed significant neurological improvement in chronic post-stroke patients — people who had plateaued well after their acute event. Single-photon emission computed tomography (SPECT) brain imaging confirmed elevated activity in previously dormant regions, consistent with reactivated neuroplasticity.
Traumatic brain injury (TBI) and post-concussion syndrome. Multiple trials have shown improved neurocognitive function in patients with chronic post-concussion deficits, including cases treated years after the original injury — well past the window when conventional medicine considers meaningful recovery possible.
Healthy aging and cognition. A randomized controlled trial in 63 healthy older adults, published in Aging, found significant improvements in global cognitive function after 60 HBOT sessions — with the biggest gains in attention and information processing speed. The mechanism appeared to involve regional changes in cerebral blood flow.
Biological aging itself. Perhaps most remarkable: a 2020 study published in Aging demonstrated that the Sagol Center’s HBOT protocol increased telomere length and reduced the number of senescent (aging, inflammatory) cells in healthy older adults. Efrati claims this is the first therapeutic intervention demonstrated to reverse both of these biological hallmarks of aging in humans simultaneously. For context on why telomere length matters for aging, see our article on The Telomere Effect.
Post-traumatic stress disorder (PTSD). Clinical trials showed significant symptom reduction in both military veterans and civilian patients with PTSD, often after years of failed conventional treatment.
Long COVID. Trials beginning in 2021 showed cognitive and functional improvements in Long COVID patients, with neuroimaging confirming changes in brain connectivity and function.
Fibromyalgia. A randomized controlled trial showed meaningful symptom improvement in fibromyalgia patients with a history of childhood sexual abuse — a notoriously treatment-resistant population.
Athletic performance. A blinded randomized controlled trial in healthy middle-aged master athletes found improvements in VO2 max (maximum oxygen uptake, a key measure of cardiovascular fitness — see our article on VO2 Max), power output, and VO2 AT (anaerobic threshold), with the underlying mechanism appearing to involve improved mitochondrial respiration and increased mitochondrial mass.
That is a remarkable breadth of evidence for a single intervention — and it is real, peer-reviewed evidence, not case studies from a wellness blog.
What Beyond Normal Does Well
It is genuinely readable. Efrati explains complex molecular biology accessibly without dumbing it down. The science of mitochondrial biogenesis, neurogenesis, angiogenesis, and stem cell proliferation is laid out clearly for a non-specialist reader. Kirkus Reviews noted it is “an engaging and approachable medical text” — a somewhat rare compliment in this genre.
The patient stories are grounding. Stroke survivors regaining speech. Veterans breaking free from PTSD after years of ineffective treatment. Concussion patients returning to normal cognitive function years post-injury. These are not cherry-picked anecdotes but representative cases from a large clinical database, and they give weight to what might otherwise feel like speculative science.
The “enhanced medicine” philosophy is coherent and timely. The argument that medicine should aim for optimization rather than mere restoration connects to a broader movement in preventive and longevity medicine that readers of Outlive by Dr. Peter Attia or Lifespan by Dr. David Sinclair will find familiar. Efrati is staking out a coherent position — reactive medicine is failing us, and the tools to do better exist right now. This resonates with the Reversing Aging framework we cover at Keep.Health.
The endorsements are not fluff. Nir Barzilai (Albert Einstein College of Medicine, author of Age Later), Eric Verdin (president and CEO of the Buck Institute for Research on Aging), David Perlmutter (neurologist and author of Grain Brain), and Joseph Maroon (professor of neurological surgery at the University of Pittsburgh) are not people who casually endorse wellness books. Their enthusiasm here reflects genuine respect for the underlying research.
What to Read Critically
No review worth its salt lets enthusiasm go unchecked. A few honest caveats:
The protocol is not plug-and-play. Throughout the book, Efrati emphasizes — correctly — that the HBOT results his team achieved depend on a very specific clinical protocol: a precise pressure (typically 2.0 atmospheres absolute, or ATA), 100% oxygen, and a carefully timed intermittent breathing pattern. The at-home hyperbaric chambers available for purchase online operate at much lower pressures (typically 1.3–1.5 ATA) and are not capable of replicating this effect. Efrati warns against them explicitly. If you finish this book and order a “mild” hyperbaric tent for your living room, you have missed the point.
Many conditions are still early-stage evidence. The neuroplasticity work on stroke and traumatic brain injury (TBI) is the most robust, with multiple randomized controlled trials. The aging reversal data, while striking, is based on a single study of 35 treated participants. The Alzheimer’s research is in earlier stages. The book’s enthusiasm occasionally runs a few years ahead of the evidence base.
Availability and cost are real barriers. The clinical HBOT protocol Efrati describes — 60 sessions, 90 minutes each, five days per week — is a significant time and financial commitment. It is available through facilities like Aviv Clinics in the U.S., but this is not yet mainstream medicine. The book would benefit from a more grounded discussion of how to access these treatments practically.
The personal health chapter is the weakest. Foreword Reviews noted that the section covering Efrati’s own diet, fitness, and supplement regimen “is a too-personalized case” for the book’s broader thesis. This section reads more like a celebrity health profile than a clinical argument, and it slightly undercuts the scientific rigor of the preceding chapters.
Key Takeaways from our Book Review of Beyond Normal
- Medicine’s goal should be optimization, not just restoration to “normal” — this is the philosophical core of enhanced medicine.
- The hyperoxic-hypoxic paradox — triggering the body’s regenerative response via precisely calibrated oxygen fluctuations — is a genuinely novel and evidence-backed mechanism for inducing neuroplasticity, stem cell activity, angiogenesis, and mitochondrial proliferation.
- Clinical evidence for HBOT’s neurological benefits in stroke, TBI, and post-concussion syndrome is among the strongest in the field, supported by multiple randomized controlled trials.
- Evidence for effects on biological aging markers (telomere length, senescent cells), cognitive enhancement in healthy older adults, PTSD, Long COVID, and athletic performance exists and is compelling — but varies in robustness.
- Consumer HBOT devices are not a substitute for clinical protocols. Pressure matters enormously.
- This is a book for anyone interested in the future of medicine, brain health, and the genuine science of healthspan optimization.
Beyond Normal Book Review: Our Verdict
Beyond Normal belongs on the same shelf as Outlive by Dr. Peter Attia and Lifespan by Dr. David Sinclair — books by serious clinician-researchers who are pushing medicine’s ambitions upward and backing it up with data. Efrati’s contribution is more focused (the HBOT angle is the through-line throughout) and the underlying research base is less well-known to general audiences, which makes it all the more worth reading.
It is not a perfect book. The personal health section is self-indulgent, some claims outrun their evidence, and the practical pathway for the average reader to actually access clinical HBOT is underexplored. But on the central question — can human beings do significantly better than “normal for their age,” and do we have credible science to support that? — Efrati makes a compelling, research-grounded case that the answer is yes.
For those interested in brain health, heat and cold therapy, biological age testing, and the emerging science of cellular reprogramming, this is essential reading. For those curious about HBOT specifically, this is the most rigorous and readable introduction to the science currently available in book form.
